Compounders Research Compare

Satellos Bioscience Inc.(MSLE)

Biotechnology · Toronto, ON

$8.12+0.06 (+0.81%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Toronto, ON

18 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Francis Gleeson

View full financials

Free Cash Flow Yield: N/A

Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The free cash flow yield is N/A as of 2026-10-06T16:17:51.872Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:17:51.872Z.

Quote observation: 2026-10-06T16:10:08.000Z. Amounts in USD. The price header may show a later quote.

TTM free cash flow · period ending 2026-06-30: -28,676,071
Quote market capitalization: 10,454,100

FMP input reference: a92f25166a0617989281a7eefd332dc08894ee274fcedbd674fe1a92e2c9d78d

Free Cash Flow CAGR|Earnings Yield|Dividend Yield|P/FCF Ratio|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MSLE Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

N/A

MSLE Competitors' Free Cash Flow Yield

Satellos Bioscience Inc.

Current

Market Cap

$10.45M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Polyrizon Ltd.

Market Cap

$10.47M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lisata Therapeutics, Inc.

Market Cap

$10.65M

Free Cash Flow Yield

N/A

TTM Avg

28.10%

3Y Avg

28.10%

5Y Avg

28.10%

Caring Brands, Inc.

Market Cap

$10.68M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Medicus Pharma Ltd. Common Stock

Market Cap

$10.06M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lifeward Ltd.

Market Cap

$9.92M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CytoMed Therapeutics Limited

Market Cap

$10.64M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BioVie Inc.

Market Cap

$11.02M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cerenome, Inc.

Market Cap

$10.88M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Ainos, Inc.

Market Cap

$9.72M

Free Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	FREE CASH FLOW YIELD	TTM	3Y	5Y
Satellos Bioscience Inc. (MSLE)	$10.45M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.47M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.65M	N/A	28.10%	28.10%	28.10%
Caring Brands, Inc. (CABR)vs ›	$10.68M	N/A	N/A	N/A	N/A
Medicus Pharma Ltd. Common Stock (MDCX)vs ›	$10.06M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$9.92M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.64M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.02M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.88M	N/A	N/A	N/A	N/A
Ainos, Inc. (AIMD)vs ›	$9.72M	N/A	N/A	N/A	N/A

Yield Comparison

FCF Yield

N/A

Earnings Yield

N/A

Dividend Yield

N/A

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

Shows free cash flow after capital expenditures relative to market cap
Can be compared with earnings yield and dividend yield
Can be compared with the company's historical range
Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

Free Cash Flow CAGR Earnings Yield Dividend Yield P/FCF Ratio All Metrics